Federated Hermes, Inc. Selecta Biosciences Inc Transaction History

Federated Hermes, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $162,298 - $339,131	-242,237 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.23 - $3.31 $214,420 - $577,019	-174,326 Reduced 41.85%	242,237 $298,000
Q4 2021 Feb 14, 2022	SELL	$2.89 - $4.43 $3,332 - $5,107	-1,153 Reduced 0.28%	416,563 $1.36 Million
Q3 2021 Nov 15, 2021	BUY	$3.36 - $4.62 $70,563 - $97,024	21,001 Added 5.29%	417,716 $1.74 Million
Q2 2021 Aug 16, 2021	BUY	$2.82 - $5.01 $322,988 - $573,820	114,535 Added 40.59%	396,715 $1.66 Million
Q1 2021 May 13, 2021	BUY	$2.92 - $5.07 $823,965 - $1.43 Million	282,180 New	282,180 $1.28 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.